Home>
US Stocks>
Precision Biosciences

Precision Biosciences share price today

(DTIL)

Precision Biosciences share price is $4.65 & ₹397.75 as on 30 Dec 2024, 20.28 hrs IST

$4.65

▲

-0.07

(-1.59%)

Market is closed - opens 8 PM, 30 Dec 2024

View live Precision Biosciences share price in Dollar and Rupees. Guide to invest in Precision Biosciences from India. Also see the sentimental analysis on Indian investors investing in Precision Biosciences. Get details on the Indian mutual funds that are investing in Precision Biosciences. Get Analyst recommendations and forecasts along with all the Precision Biosciences's financials.

Precision Biosciences share price movements

Today's Low: $4.61
Today's High: $4.90
$4.65
0.86%
Downside
Day's Volatility :5.92%
Upside
5.1%
52 Weeks Low: $4.13
52 Weeks High: $19.43
$4.65
11.18%
Downside
52 Weeks Volatility :78.74%
Upside
76.07%

Precision Biosciences Returns

Period	Precision Biosciences Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-48.1%	-9.8%	0.0%
6 Months	-52.98%	-4.7%	0.0%
1 Year	-58.11%	1.9%	0.0%
3 Years	-97.91%	-1.8%	-21.3%

Precision Biosciences Key Statistics

in dollars & INR

Previous Close	$4.65
Open	$4.73
Today's High	$4.9
Today's Low	$4.49
Market Capitalization	$36.2M
Today's Volume	$78.2K
52 Week High	$19.4299
52 Week Low	$4.13
Revenue TTM	$75.1M
EBITDA	$-12.0M
Earnings Per Share (EPS)	$0.4
PE Ratio	11.81
Profit Margin	11.48%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	24.44%

How to invest in Precision Biosciences from India?

It is very easy for Indian residents to invest directly in Precision Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Precision Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Precision Biosciences or DTIL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Precision Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Precision Biosciences shares which would translate to 0.184 fractional shares of Precision Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Precision Biosciences, in just a few clicks!

Returns in Precision Biosciences for Indian investors in Rupees

Investment Value

₹1,00,000

Precision Biosciences investment value today

Current value as on today

₹44,687

Returns

₹55,313

(-55.31%)

Returns from Precision Biosciences Stock

₹58,108 (-58.11%)

Dollar Returns

₹2,795 (+2.79%)

Indian investors sentiment towards Precision Biosciences

100%

Period: Sep 30, 2024 to Dec 29, 2025. Change in 30 Days versus previous period

Search volume for Precision Biosciences on INDmoney from India has grown in the last 30 days as on Dec 30, 2025. 100% more investors are searching Precision Biosciences in the last 30 days versus the previous period.

Global Institutional Holdings in Precision Biosciences

HHG PLC
9.15%
TANG CAPITAL MANAGEMENT LLC
8.13%
Perceptive Advisors LLC
5.56%
Aquilo Capital Management, LLC
4.98%
Vanguard Group Inc
3.44%
Alyeska Investment Group, L.P.
2.30%

Analyst Recommendation on Precision Biosciences

Buy

83%Buy

16%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Precision Biosciences(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Precision Biosciences

What analysts predicted

Upside of 622.58%

Current:

$4.65

Target:

$33.60

Insights on Precision Biosciences

Price Movement
In the last 1 month, DTIL stock has moved down by -36.2%
Price Movement
In the last 6 months, DTIL stock has moved up by 22.8%
Increasing Revenue
Revenue is up for the last 3 quarters, 53.46 Cr → 168.35 Cr (in ₹), with an average increase of 43.6% per quarter
Decreasing Revenue
Revenue is down for the last 2 quarters, 49.89M → 576.0K (in $), with an average decrease of 98.9% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -83.47 Cr → 25.99 Cr (in ₹), with an average increase of 1420.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 32.74M → -16.42M (in $), with an average decrease of 150.2% per quarter
DTIL vs ALNY (1 yr)
In the last 1 year, Avanti Feeds Ltd has given 40.9% return, outperforming this stock by 22.9%
DTIL vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 24.3% return, outperforming this stock by 81.8%
DTIL vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 39.1% return, outperforming this stock by 137.1%
DTIL vs VRTX (3 yr)
In the last 3 years, Kaveri Seed Company Ltd has given 58.5% return, outperforming this stock by 57.1%
Price to Sales
ForDTIL every $1 of sales, investors are willing to pay $0.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.4 for every $1 of sales.

Precision Biosciences Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$10.9M	↑ 67.84%
Net Income	$-46.0M	↑ 118.16%
Net Profit Margin	-423.02%	↓ 97.57%

	FY19	Y/Y Change
Revenue	$22.2M	↑ 104.34%
Net Income	$-83.3M	↑ 80.94%
Net Profit Margin	-374.59%	↑ 48.43%

	FY20	Y/Y Change
Revenue	$24.3M	↑ 9.2%
Net Income	$-109.0M	↑ 30.86%
Net Profit Margin	-448.86%	↓ 74.27%

	FY21	Y/Y Change
Revenue	$115.5M	↑ 375.72%
Net Income	$-30.9M	↓ 71.64%
Net Profit Margin	-26.76%	↑ 422.1%

	FY22	Y/Y Change
Revenue	$25.1M	↓ 78.28%
Net Income	$-122.9M	↑ 297.53%
Net Profit Margin	-489.71%	↓ 462.95%

	FY23	Y/Y Change
Revenue	$48.7M	↑ 94.15%
Net Income	$-61.3M	↓ 50.11%
Net Profit Margin	-125.84%	↑ 363.87%

	Q2 FY23	Q/Q Change
Revenue	$19.8M	↑ 125.39%
Net Income	$-11.9M	↓ 49.52%
Net Profit Margin	-60.09%	↑ 208.22%

	Q3 FY23	Q/Q Change
Revenue	$13.1M	↓ 33.7%
Net Income	$-8.1M	↓ 32.06%
Net Profit Margin	-61.58%	↓ 1.49%

	Q4 FY23	Q/Q Change
Revenue	$7.0M	↓ 46.36%
Net Income	$-16.3M	↑ 101.62%
Net Profit Margin	-231.44%	↓ 169.86%

	Q1 FY24	Q/Q Change
Revenue	$17.6M	↑ 149.84%
Net Income	$8.6M	↓ 152.72%
Net Profit Margin	48.84%	↑ 280.28%

	Q2 FY24	Q/Q Change
Revenue	$49.9M	↑ 183.77%
Net Income	$32.7M	↑ 281.33%
Net Profit Margin	65.63%	↑ 16.79%

	Q3 FY24	Q/Q Change
Revenue	$576.0K	↓ 98.85%
Net Income	$-16.4M	↓ 150.15%
Net Profit Margin	-2.9K%	↓ 2917.19%

	FY18	Y/Y Change
Profit	$10.9M	↑ 67.84%

	FY19	Y/Y Change
Profit	$22.2M	↑ 104.34%

	FY20	Y/Y Change
Profit	$24.3M	↑ 9.2%

	FY21	Y/Y Change
Profit	$115.5M	↑ 375.72%

	FY22	Y/Y Change
Profit	$16.1M	↓ 86.07%

	FY23	Y/Y Change
Profit	$40.5M	↑ 151.47%

	Q2 FY23	Q/Q Change
Profit	$17.4M	↑ 167.67%

	Q3 FY23	Q/Q Change
Profit	$11.1M	↓ 36.31%

	Q4 FY23	Q/Q Change
Profit	$5.5M	↓ 50.54%

	Q1 FY24	Q/Q Change
Profit	$16.2M	↑ 194.73%

	Q2 FY24	Q/Q Change
Profit	$48.5M	↑ 200.28%

	Q3 FY24	Q/Q Change
Profit	$-435.0K	↓ 100.9%

	FY18	Y/Y Change
Operating Cash Flow	$-51.7M	↑ 114.01%
Investing Cash Flow	$-15.7M	↑ 184.01%
Financing Cash Flow	$107.8M	↓ 11602.35%

	FY19	Y/Y Change
Operating Cash Flow	$-71.0M	↑ 37.3%
Investing Cash Flow	$-24.7M	↑ 57.48%
Financing Cash Flow	$173.4M	↑ 60.86%

	FY20	Y/Y Change
Operating Cash Flow	$-87.4M	↑ 23.05%
Investing Cash Flow	$-5.0M	↓ 79.6%
Financing Cash Flow	$1.3M	↓ 99.23%

	FY21	Y/Y Change
Operating Cash Flow	$-10.9M	↓ 87.58%
Investing Cash Flow	$-5.8M	↑ 15.34%
Financing Cash Flow	$70.5M	↑ 5206.32%

	FY22	Y/Y Change
Operating Cash Flow	$-45.8M	↑ 321.57%
Investing Cash Flow	$-3.3M	↓ 42.81%
Financing Cash Flow	$95.0M	↑ 34.69%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-21.1M	↓ 32.83%
Investing Cash Flow	$-1.1M	↑ 46.46%
Financing Cash Flow	$1.9M	↑ 149.93%

Precision Biosciences Technicals Summary

Sell

Neutral

Buy

Precision Biosciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Precision Biosciences Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Precision Biosciences Inc	-32.31%	-52.98%	-58.11%	-97.91%	-98.82%
Regeneron Pharmaceuticals, Inc.	-6.55%	-32.6%	-21.28%	12.81%	90.81%
Biontech Se	-2.77%	44.55%	1.43%	-55.8%	195.97%
Alnylam Pharmaceuticals, Inc.	-5.94%	-2.2%	22.08%	40.33%	105.82%
Vertex Pharmaceuticals Incorporated	-12.23%	-13.26%	-0.52%	86.14%	86.27%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Precision Biosciences Inc	11.81	11.81	NA	1.03	0.24	-0.06	NA	8.67
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.07	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Precision Biosciences Inc	Buy	$36.2M	-98.82%	11.81	11.48%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	90.81%	17.67	33.61%
Biontech Se	Buy	$27.3B	195.97%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.3B	105.82%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.8B	86.27%	32.84	-4.51%

About Precision Biosciences

precision biosciences, inc. is a biotechnology company located in durham, north carolina, united states.

Organization	Precision Biosciences
Employees	108
CEO	Mr. Michael Amoroso
Industry	Biotechnology

Management People of Precision Biosciences

Name	Title
Mr. Michael Amoroso	President, CEO & Director
Mr. John Alexander Kelly R.Ph.	CFO & Principal Accounting Officer
Dr. Jefferson J. Smith Ph.D.	Co-Founder & Chief Research Officer
Mr. Naresh Tanna	Chief of Staff to CEO & Head of Investor Relations
Mr. Dario Scimeca J.D.	General Counsel & Secretary
Mr. Bruce Stevens	Vice President of Quality & Compliance
Maurissa Messier	Senior Director of Corporate Communications
Ms. Juli Blanche	Chief People Officer
Mr. Garrett Gincley	Head of Manufacturing
Ms. Cindy Atwell	Chief Business Officer

Important FAQs about investing in Precision Biosciences from India :

What is Precision Biosciences share price today?

Precision Biosciences share price today stands at $4.65, Open: $4.73 ; Previous Close: $4.72 ; High: $4.90 ; Low: $4.61 ; 52 Week High: $19.43 ; 52 Week Low: $4.13. The stock opens at $4.73, after a previous close of $4.72. The stock reached a daily high of $4.90 and a low of $4.61, with a 52-week high of $19.43 and a 52-week low of $4.13.

Can Indians buy Precision Biosciences shares?

Yes, Indians can invest in the Precision Biosciences (DTIL) from India.

With INDmoney, you can buy Precision Biosciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Precision Biosciences at zero transaction cost.

How can I buy Precision Biosciences shares from India?

It is very easy to buy Precision Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Precision Biosciences be purchased?

Yes, you can buy fractional shares of Precision Biosciences with INDmoney app.

What are the documents required to start investing in Precision Biosciences stocks?

To start investing in Precision Biosciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.